Evolus, Inc. (EOLS) Can’t Burn Your Short Portfolio. Just Reaches All-Time Low

April 28, 2018 - By Hazel Jackson

The stock of Evolus, Inc. (NASDAQ:EOLS) reached all time low today, Apr, 28 and still has $6.42 target or 9.00 % below today’s $7.06 share price. This indicates more downside for the $166.90 million company. This technical setup was reported by Barchart.com. If the $6.42 PT is reached, the company will be worth $15.02 million less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only.

The stock decreased 2.08% or $0.15 during the last trading session, reaching $7.06. About 110,722 shares traded. Evolus, Inc. (NASDAQ:EOLS) has 0.00% since April 28, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts await Evolus, Inc. (NASDAQ:EOLS) to report earnings on July, 5. After $0.24 actual earnings per share reported by Evolus, Inc. for the previous quarter, Wall Street now forecasts -250.00 % negative EPS growth.

Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. The company has market cap of $166.90 million. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.